Showing results (331-340 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|October 5, 2001
Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medicationA L Drapalski, R B Rosse, R R Peebles, et al.Clinical Neuropharmacology|October 5, 2001
Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's diseaseS A Factor, E S Molho, P J Feustel, et al.Clinical Neuropharmacology|October 5, 2001
Acute mania and hemichoreaR Inzelberg, P Nisipeanu, D Joel, et al.Clinical Neuropharmacology|August 2, 2001
Response of catatonia to risperidone: two case reportsA Valevski, T Loebl, T Keren, et al.Clinical Neuropharmacology|August 2, 2001
Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosisD S Sa, S Kapur, A E LangClinical Neuropharmacology|June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidolB Angrist, M Sanfilipo, A WolkinClinical Neuropharmacology|June 8, 2001
Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxismG J Lavigne, J P Soucy, F Lobbezoo, et al.Clinical Neuropharmacology|June 8, 2001
Continuous transdermal dopaminergic stimulation in advanced Parkinson's diseaseL V Metman, M Gillespie, C Farmer, et al.Clinical Neuropharmacology|November 15, 2019
Rocuronium Continuous Infusion for Profound Neuromuscular Blockade: A Systematic Review and Meta-analysisMafalda Couto, Catarina Nunes, Sérgio Vide, et al.Pageof 236